Real-time enrollment status for this erosive esophagitis clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 11:26 PM UTC
| NCT Number | NCT05267613 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Erosive Esophagitis |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 16 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of June 1, 2026: Clinical trial NCT05267613 is currently active_not_recruiting participants. This clinical trial study for erosive esophagitis is not currently accepting new participants at 16 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05267613 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05267613 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.